Expression and structural features of endoglin (CD105), a transforming growth factor /B1 and /B3 binding protein, in human melanoma
1996

Endoglin Expression in Melanoma

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): M Altomonte, R Montagner, E Fonsatti, F Colizzi, I Cattarossi, LI Brasoveanu, MR Nicotra, A Cattelan, PG Natali, M Maio

Primary Institution: Centro di Riferimento Oncologico, Aviano, Italy

Hypothesis

Does endoglin (CD105) play a role in the growth regulation of melanoma cells by binding TGF-beta?

Conclusion

Endoglin is expressed in melanoma cells and can regulate their growth in response to TGF-beta.

Supporting Evidence

  • CD105 is expressed on normal and neoplastic cells of the melanocytic lineage.
  • 50% of intradermal naevi, 25% of primary melanomas, and 34% of metastatic melanomas were positive for CD105.
  • Exogenous TGF-beta1 significantly inhibited the growth of CD105-positive melanoma cells.

Takeaway

This study found that a protein called endoglin is present in melanoma cells and helps control their growth when a specific growth factor is added.

Methodology

Immunohistochemical analyses and SDS-PAGE were used to study endoglin expression and its binding to TGF-beta in melanoma cells.

Limitations

The study did not explore the expression of TGF-beta receptors in melanoma cells.

Participant Demographics

Patients with benign naevi and melanoma lesions.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication